A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension
Clinical trial NCT01672476 · COMPLETED
Trial details
- NCT number
- NCT01672476
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-03-01
- Enrollment
- 293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.